Turkish Journal of Nephrology
Original Article

Starting of Renal Replacement Treatment: Two Years Experience

1.

Division of Nephrology, Akdeniz University School of Medicine, Antalya, Turkey

2.

Department of Internal Medicine, Akdeniz University School of Medicine, Antalya, Turkey

Turkish J Nephrol 2019; 28: 286-292
DOI: 10.5152/turkjnephrol.2019.3571
Read: 743 Downloads: 223 Published: 04 November 2019

Objective: It is still unclear which parameters will be used when starting renal replacement therapies (RRT) in end stage kidney disease patients. We planned this retrospective study to determine the eGFR in the transition to RRT in our patient population and the RRT preferences with laboratory values.

Materials and Methods: We data from patients who transferred to RRT from low-clearance polyclinic between 2016 and 2017.

Results: 57 patients underwent hemodialysis (HD), 13 patients  peritoneal dialysis (PD) and 24 patients preemptive kidney transplantation. In the middle age group (56-75 years), HD was more preferred then preemptive kidney transplantation (p=0.02). In the transition to RRT median eGFR is 8.3 (6.7-9.6) mL/min/1.73 m2. A statistically significant difference was found between eGFR values when starting different RRTs (p= 0.005). The median eGFRs for HD is 7.4 (5.9-9) mL/min/1.73 m2, for PD 8.6 mL/min/1.73 m2 (7.9-10.6), for transplantation 9.3 (7.25-11.2) mL/min/1.73 m2. This difference was between preemptive transplantation and HD.

Conclusion: It is not appropriate to decide the RRT with a single assessment other than acute complications. Prolongation of the stage 5 chronic kidney disease follow-up may imply postponement of the cost of other high-cost RRTs.

Cite this article as: Bora F, Avşar E, Asar E, Sarı F, Ersoy F, Çetinkaya R, et al. Starting of Renal Replacement Treatment: Two Years Experience. Turk J Nephrol 2019; 28(4): 286-92.

Files
EISSN 2667-4440